{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:32:07Z","timestamp":1768681927630,"version":"3.49.0"},"reference-count":152,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:00:00Z","timestamp":1376352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Rodrigo Liberal was supported by a doctoral grant from the Foundation for Science and Technology in Lisbon, Portugal","award":["SFRH\/BD\/65007\/2009"],"award-info":[{"award-number":["SFRH\/BD\/65007\/2009"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Liver transplantation (LT) is an effective treatment for patients with end-stage autoimmune liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Indications for LT for these diseases do not differ substantially from those used for other acute or chronic liver diseases. Despite the good outcomes reported, the recurrence of autoimmune liver disease is relatively common in the allograft. In addition, it has become apparent that autoimmunity and autoimmune liver disease can arise de novo after transplantation for nonautoimmune liver disorders. An awareness of the existence of recurrent autoimmune liver diseases and de novo autoimmune hepatitis after LT has important clinical implications because their management differs from the standard antirejection treatment and is similar to the management of classic autoimmune liver diseases in the native liver. <jats:italic toggle=\"yes\">Liver Transpl 19:1065-1077, 2013<\/jats:italic>. \u00a9 2013 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.23704","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T10:58:45Z","timestamp":1374231525000},"page":"1065-1077","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":86,"title":["Liver transplantation and autoimmune liver diseases"],"prefix":"10.1097","volume":"19","author":[{"given":"Rodrigo","family":"Liberal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 6","key":"R1-4-20250124","first-page":"VI1VI22","article-title":"Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.","volume":"45","author":"Devlin","year":"1999","journal-title":"Gut"},{"key":"R2-4-20250124","doi-asserted-by":"crossref","first-page":"941956","DOI":"10.1016\/S1089-3261(03)00099-0","article-title":"Liver transplantation for primary biliary cirrhosis.","volume":"7","author":"MacQuillan","year":"2003","journal-title":"Clin Liver Dis"},{"key":"R3-4-20250124","doi-asserted-by":"crossref","first-page":"33883395","DOI":"10.3748\/wjg.14.3388","article-title":"Transplantation in autoimmune liver diseases.","volume":"14","author":"Mottershead","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R4-4-20250124","doi-asserted-by":"crossref","first-page":"667680","DOI":"10.1053\/bega.2001.0212","article-title":"Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.","volume":"15","author":"Wiesner","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R5-4-20250124","first-page":"215221","article-title":"Prognostic features and role of liver transplantation in severe corticosteroidtreated autoimmune chronic active hepatitis.","volume":"15","author":"SanchezUrdazpal","year":"1992","journal-title":"Hepatology"},{"key":"R7-4-20250124","doi-asserted-by":"crossref","first-page":"227247","DOI":"10.1016\/j.cld.2007.04.008","article-title":"Current indications and contraindications for liver transplantation.","volume":"11","author":"Ahmed","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R8-4-20250124","doi-asserted-by":"crossref","first-page":"625631","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-4-20250124","doi-asserted-by":"crossref","first-page":"765782","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases.","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R10-4-20250124","doi-asserted-by":"crossref","first-page":"271276","DOI":"10.1053\/jhep.2002.35339","article-title":"Autoimmunity after liver transplantation.","volume":"36","author":"Vergani","year":"2002","journal-title":"Hepatology"},{"key":"R11-4-20250124","doi-asserted-by":"crossref","first-page":"702717","DOI":"10.1016\/j.jhep.2011.03.005","article-title":"What is the longterm outcome of the liver allograft?","volume":"55","author":"Hubscher","year":"2011","journal-title":"J Hepatol"},{"key":"R12-4-20250124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation.","volume":"306","author":"Neuberger","year":"1982","journal-title":"N Engl J Med"},{"key":"R13-4-20250124","doi-asserted-by":"crossref","first-page":"356361","DOI":"10.1002\/hep.1840200214","article-title":"Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?","volume":"20","author":"Harrison","year":"1994","journal-title":"Hepatology"},{"key":"R14-4-20250124","doi-asserted-by":"crossref","first-page":"363365","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.","volume":"37","author":"Neuberger","year":"1984","journal-title":"Transplantation"},{"key":"R15-4-20250124","doi-asserted-by":"crossref","first-page":"505513","DOI":"10.1053\/jlts.2002.33485","article-title":"Autoimmune hepatitis after liver transplantation and other lessons of selfintolerance.","volume":"8","author":"Czaja","year":"2002","journal-title":"Liver Transpl"},{"key":"R16-4-20250124","doi-asserted-by":"crossref","first-page":"14221429","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-4-20250124","doi-asserted-by":"crossref","first-page":"210225","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"R18-4-20250124","doi-asserted-by":"crossref","first-page":"12611273","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis.","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"R19-4-20250124","doi-asserted-by":"crossref","first-page":"16001609","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis.","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"R20-4-20250124","doi-asserted-by":"crossref","first-page":"35253531","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis.","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"R22-4-20250124","doi-asserted-by":"crossref","first-page":"13131315","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis.","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-4-20250124","doi-asserted-by":"crossref","first-page":"17991807","DOI":"10.1111\/j.1572-0241.2007.01235.x","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and metaanalysis of randomized clinical trials using Bayesian approach as sensitivity analyses.","volume":"102","author":"Gong","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R24-4-20250124","first-page":"183188","article-title":"Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis.","volume":"2","author":"Garcia","year":"2004","journal-title":"Exp Clin Transplant"},{"key":"R25-4-20250124","doi-asserted-by":"crossref","first-page":"13621369","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseasesan analysis of the UNOS database.","volume":"14","author":"Kashyap","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R26-4-20250124","doi-asserted-by":"crossref","first-page":"10861093","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history.","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"key":"R27-4-20250124","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a longterm pathologic study.","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"},{"key":"R28-4-20250124","doi-asserted-by":"crossref","first-page":"588595","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological followup study.","volume":"7","author":"Hashimoto","year":"2001","journal-title":"Liver Transpl"},{"key":"R29-4-20250124","doi-asserted-by":"crossref","first-page":"15831588","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"suppl 3","key":"R30-4-20250124","first-page":"S128S136","article-title":"Model for EndStage Liver Disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"},{"key":"R31-4-20250124","doi-asserted-by":"crossref","first-page":"14541461","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R32-4-20250124","doi-asserted-by":"crossref","first-page":"142148","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence.","volume":"39","author":"Neuberger","year":"2003","journal-title":"J Hepatol"},{"key":"R33-4-20250124","doi-asserted-by":"crossref","first-page":"959969","DOI":"10.2741\/3966","article-title":"Liver transplantation in chronic cholestatic conditions.","volume":"17","author":"Milkiewicz","year":"2012","journal-title":"Front Biosci"},{"key":"R34-4-20250124","doi-asserted-by":"crossref","first-page":"472481","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12year single center experience.","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"key":"R35-4-20250124","doi-asserted-by":"crossref","first-page":"11211127","DOI":"10.1002\/hep.510300501","article-title":"Longterm results of patients undergoing liver transplantation for primary sclerosing cholangitis.","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R36-4-20250124","doi-asserted-by":"crossref","first-page":"451457","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplantation for sclerosing cholangitis.","volume":"22","author":"Narumi","year":"1995","journal-title":"Hepatology"},{"key":"R37-4-20250124","doi-asserted-by":"crossref","first-page":"10501056","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation.","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R38-4-20250124","doi-asserted-by":"crossref","first-page":"792798","DOI":"10.1016\/S0168-8278(01)00042-3","article-title":"Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study.","volume":"34","author":"Leidenius","year":"2001","journal-title":"J Hepatol"},{"issue":"pt 1","key":"R39-4-20250124","first-page":"693700","article-title":"Liver transplantation for autoimmune hepatitis.","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"R41-4-20250124","doi-asserted-by":"crossref","first-page":"16451650","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation.","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"R42-4-20250124","doi-asserted-by":"crossref","first-page":"459465","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"R43-4-20250124","doi-asserted-by":"crossref","first-page":"136139","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease.","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"R44-4-20250124","doi-asserted-by":"crossref","first-page":"162165","DOI":"10.1002\/lt.500010305","article-title":"Recurrence of autoimmune hepatitis following liver transplantation.","volume":"1","author":"Devlin","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"R45-4-20250124","first-page":"2025","article-title":"Recurrence of autoimmune hepatitis in children after liver transplantation.","volume":"25","author":"Birnbaum","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R46-4-20250124","doi-asserted-by":"crossref","first-page":"131141","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Longterm followup after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"R47-4-20250124","doi-asserted-by":"crossref","first-page":"430431","DOI":"10.1016\/S0041-1345(98)01692-3","article-title":"Recurrence of autoimmune hepatitis after liver transplantation.","volume":"31","author":"Gotz","year":"1999","journal-title":"Transplant Proc"},{"key":"R48-4-20250124","doi-asserted-by":"crossref","first-page":"253256","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation.","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"R49-4-20250124","doi-asserted-by":"crossref","first-page":"185192","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a longterm pathologic study.","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"issue":"pt 1","key":"R50-4-20250124","first-page":"868870","article-title":"Recurrent autoimmune hepatitis after liver transplantationwhen nonself becomes self.","volume":"32","author":"Manns","year":"2000","journal-title":"Hepatology"},{"key":"R51-4-20250124","first-page":"302310","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation.","volume":"7","author":"GonzalezKoch","year":"2001","journal-title":"Liver Transpl"},{"key":"R52-4-20250124","first-page":"893897","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"DuclosVallee","year":"2003","journal-title":"Gut"},{"key":"R53-4-20250124","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Longterm outcome of liver transplantation for autoimmune hepatitis.","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"R55-4-20250124","doi-asserted-by":"crossref","first-page":"13701378","DOI":"10.1111\/j.1572-0241.2006.00586.x","article-title":"Recurrence of diseases following orthotopic liver transplantation.","volume":"101","author":"Kotlyar","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R56-4-20250124","doi-asserted-by":"crossref","first-page":"12811286","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R58-4-20250124","doi-asserted-by":"crossref","first-page":"19551956","DOI":"10.1016\/S0041-1345(99)00227-4","article-title":"Liver transplantation for autoimmune hepatitis: rejection and recurrence.","volume":"31","author":"Narumi","year":"1999","journal-title":"Transplant Proc"},{"key":"R59-4-20250124","doi-asserted-by":"crossref","first-page":"356364","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease.","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"R61-4-20250124","doi-asserted-by":"crossref","first-page":"377383","DOI":"10.1097\/MOG.0b013e3282f9e239","article-title":"An update on primary sclerosing cholangitis.","volume":"24","author":"Maggs","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"R62-4-20250124","doi-asserted-by":"crossref","first-page":"727739","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis.","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R63-4-20250124","first-page":"237267","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases.","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"R64-4-20250124","doi-asserted-by":"crossref","first-page":"11601165","DOI":"10.1016\/S0016-5085(83)80085-7","article-title":"Familial occurrence of primary sclerosing cholangitis and ulcerative colitis.","volume":"85","author":"Quigley","year":"1983","journal-title":"Gastroenterology"},{"key":"R65-4-20250124","doi-asserted-by":"crossref","first-page":"655664","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a longterm followup study.","volume":"22","author":"Aadland","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"R66-4-20250124","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1136\/gut.2004.046615","article-title":"PSCIBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"R67-4-20250124","doi-asserted-by":"crossref","first-page":"753764","DOI":"10.1016\/j.bpg.2011.10.002","article-title":"Primary sclerosing cholangitis and malignancy.","volume":"25","author":"Boberg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R68-4-20250124","doi-asserted-by":"crossref","first-page":"14161421","DOI":"10.1111\/j.1600-6143.2006.01321.x","article-title":"Waiting list removal rates among patients with chronic and malignant liver diseases.","volume":"6","author":"Freeman","year":"2006","journal-title":"Am J Transplant"},{"key":"R69-4-20250124","doi-asserted-by":"crossref","first-page":"236245","DOI":"10.1097\/MOG.0b013e328337b311","article-title":"An update on cholangiocarcinoma associated with primary sclerosing cholangitis.","volume":"26","author":"Fevery","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"R70-4-20250124","doi-asserted-by":"crossref","first-page":"455459","DOI":"10.1016\/j.jhep.2007.07.003","article-title":"Cholangiocarcinoma: is transplantation an option? For whom?","volume":"47","author":"Gores","year":"2007","journal-title":"J Hepatol"},{"key":"R71-4-20250124","doi-asserted-by":"crossref","first-page":"602604","DOI":"10.1097\/01.TP.0000113807.74942.D2","article-title":"RouxenY choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis.","volume":"77","author":"Welsh","year":"2004","journal-title":"Transplantation"},{"key":"R72-4-20250124","doi-asserted-by":"crossref","first-page":"882886","DOI":"10.1002\/bjs.6210","article-title":"Ileal pouchanal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis.","volume":"95","author":"Mathis","year":"2008","journal-title":"Br J Surg"},{"key":"R73-4-20250124","doi-asserted-by":"crossref","first-page":"544553","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitissclerosing cholangitis overlap syndrome in childhood: a 16year prospective study.","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"R75-4-20250124","doi-asserted-by":"crossref","first-page":"653664","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis.","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R76-4-20250124","doi-asserted-by":"crossref","first-page":"241253","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis.","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"R77-4-20250124","doi-asserted-by":"crossref","first-page":"421435","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis.","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"R78-4-20250124","doi-asserted-by":"crossref","first-page":"159185","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"R79-4-20250124","doi-asserted-by":"crossref","first-page":"820833","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"R80-4-20250124","first-page":"735737","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis.","volume":"1","author":"MurrayLyon","year":"1973","journal-title":"Lancet"},{"key":"R81-4-20250124","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"key":"R82-4-20250124","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients.","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R83-4-20250124","doi-asserted-by":"crossref","first-page":"848857","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R84-4-20250124","doi-asserted-by":"crossref","first-page":"10511057","DOI":"10.1111\/j.1365-2036.2006.03104.x","article-title":"Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.","volume":"24","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R85-4-20250124","doi-asserted-by":"crossref","first-page":"14101414","DOI":"10.1111\/j.1440-1746.2008.05365.x","article-title":"Favorable outcomes of autoimmune hepatitis in a community clinic setting.","volume":"23","author":"Seo","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R86-4-20250124","doi-asserted-by":"crossref","first-page":"19801989","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Longterm outcomes of patients with autoimmune hepatitis managed at a nontransplant center.","volume":"140","author":"Hoeroldt","year":"2011","journal-title":"Gastroenterology"},{"key":"R87-4-20250124","doi-asserted-by":"crossref","first-page":"273285","DOI":"10.1055\/s-0029-1233534","article-title":"Treatment of autoimmune hepatitis.","volume":"29","author":"Strassburg","year":"2009","journal-title":"Semin Liver Dis"},{"key":"R88-4-20250124","doi-asserted-by":"crossref","first-page":"9961003","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"R89-4-20250124","doi-asserted-by":"crossref","first-page":"20702075","DOI":"10.3748\/wjg.v17.i16.2070","article-title":"Optimizing management in autoimmune hepatitis with liver failure at initial presentation.","volume":"17","author":"Potts","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R90-4-20250124","doi-asserted-by":"crossref","first-page":"13471353","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminanttype autoimmune hepatitis: an analysis of eleven cases.","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R91-4-20250124","doi-asserted-by":"crossref","first-page":"15101516","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R92-4-20250124","doi-asserted-by":"crossref","first-page":"448453","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroidtreated severe autoimmune chronic active hepatitis.","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"R93-4-20250124","doi-asserted-by":"crossref","first-page":"926934","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"R94-4-20250124","doi-asserted-by":"crossref","first-page":"953955","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation.","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transpl"},{"key":"R95-4-20250124","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis.","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"R96-4-20250124","first-page":"173184","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation.","volume":"18","author":"Hubscher","year":"1993","journal-title":"J Hepatol"},{"key":"R97-4-20250124","doi-asserted-by":"crossref","first-page":"253257","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression.","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J Hepatol"},{"key":"R98-4-20250124","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"suppl 2","key":"R99-4-20250124","first-page":"S25S34","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.","volume":"15","author":"DuclosVallee","year":"2009","journal-title":"Liver Transpl"},{"key":"R100-4-20250124","doi-asserted-by":"crossref","first-page":"539546","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis.","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"key":"R101-4-20250124","doi-asserted-by":"crossref","first-page":"284287","DOI":"10.1016\/S0168-8278(05)80206-5","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation following FK506based immunosuppression.","volume":"17","author":"Wong","year":"1993","journal-title":"J Hepatol"},{"key":"R102-4-20250124","doi-asserted-by":"crossref","first-page":"243249","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients.","volume":"63","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"key":"R103-4-20250124","doi-asserted-by":"crossref","first-page":"211220","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Longterm followup after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"R104-4-20250124","doi-asserted-by":"crossref","first-page":"720726","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation.","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"key":"R105-4-20250124","doi-asserted-by":"crossref","first-page":"19431944","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"R106-4-20250124","doi-asserted-by":"crossref","first-page":"13001306","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"R107-4-20250124","doi-asserted-by":"crossref","first-page":"727732","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"key":"R108-4-20250124","doi-asserted-by":"crossref","first-page":"181185","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R109-4-20250124","doi-asserted-by":"crossref","first-page":"330340","DOI":"10.1002\/lt.21679","article-title":"A reevaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"R110-4-20250124","doi-asserted-by":"crossref","first-page":"311315","DOI":"10.1111\/j.1600-0676.1997.tb01038.x","article-title":"Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation.","volume":"17","author":"Sempoux","year":"1997","journal-title":"Liver"},{"key":"R111-4-20250124","doi-asserted-by":"crossref","first-page":"460463","DOI":"10.1002\/lt.500050512","article-title":"The immunoreactive propensity of autoimmune hepatitis: is it corticosteroiddependent after liver transplantation?","volume":"5","author":"Czaja","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R112-4-20250124","first-page":"12541261","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation.","volume":"15","author":"MontanoLoza","year":"2009","journal-title":"Liver Transpl"},{"key":"R113-4-20250124","doi-asserted-by":"crossref","first-page":"409413","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"Denovo autoimmune hepatitis after liver transplantation.","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R114-4-20250124","doi-asserted-by":"crossref","first-page":"464470","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"R115-4-20250124","first-page":"128135","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in livingdonor liver transplantation.","volume":"78","author":"MiyagawaHayashino","year":"2004","journal-title":"Transplantation"},{"key":"R116-4-20250124","doi-asserted-by":"crossref","first-page":"955963","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transplant"},{"key":"R117-4-20250124","first-page":"14261433","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.","volume":"32","author":"MontanoLoza","year":"2012","journal-title":"Liver Int"},{"key":"R118-4-20250124","doi-asserted-by":"crossref","first-page":"12521257","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment postliver transplant.","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"key":"R119-4-20250124","doi-asserted-by":"crossref","first-page":"12361245","DOI":"10.1002\/lt.21124","article-title":"Longterm survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"R120-4-20250124","doi-asserted-by":"crossref","first-page":"446454","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence.","volume":"35","author":"Carbone","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R121-4-20250124","doi-asserted-by":"crossref","first-page":"349356","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation.","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"R122-4-20250124","doi-asserted-by":"crossref","first-page":"16911692","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.","volume":"37","author":"Jacob","year":"2005","journal-title":"Transplant Proc"},{"key":"R123-4-20250124","first-page":"11491154","article-title":"Phenotypic expression of recurrent disease after liver transplantation.","volume":"10","author":"OGrady","year":"2010","journal-title":"Am J Transplant"},{"key":"R124-4-20250124","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1097\/00000478-199501000-00010","article-title":"Sclerosing cholangitis following human orthotopic liver transplantation.","volume":"19","author":"Sebagh","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R125-4-20250124","doi-asserted-by":"crossref","first-page":"E163E169","DOI":"10.1111\/j.1399-0012.2010.01300.x","article-title":"Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiographylongterm followup.","volume":"24","author":"Katz","year":"2010","journal-title":"Clin Transplant"},{"key":"R126-4-20250124","doi-asserted-by":"crossref","first-page":"575581","DOI":"10.1053\/jlts.2002.33952","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"8","author":"Graziadei","year":"2002","journal-title":"Liver Transpl"},{"key":"R127-4-20250124","doi-asserted-by":"crossref","first-page":"138143","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"suppl 1","key":"R128-4-20250124","first-page":"555A","article-title":"Outcome and survival in childhood onset autoimmune sclerosing cholangitis and autoimmune hepatitis; a 13 years followup study abstract.","volume":"46","author":"Scalori","year":"2007","journal-title":"Hepatology"},{"key":"R129-4-20250124","doi-asserted-by":"crossref","first-page":"18131824","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review.","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"R130-4-20250124","doi-asserted-by":"crossref","first-page":"9981005","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group.","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"R131-4-20250124","doi-asserted-by":"crossref","first-page":"929938","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R133-4-20250124","doi-asserted-by":"crossref","first-page":"556558","DOI":"10.1053\/jlts.2001.24638","article-title":"Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient.","volume":"7","author":"Hurtova","year":"2001","journal-title":"Liver Transpl"},{"key":"R134-4-20250124","doi-asserted-by":"crossref","first-page":"10851089","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats posttransplant autoimmune hepatitis.","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"R135-4-20250124","doi-asserted-by":"crossref","first-page":"346353","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation.","volume":"10","author":"Liberal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R136-4-20250124","first-page":"131136","article-title":"Autoimmune hepatitis as a late complication of liver transplantation.","volume":"32","author":"Hernandez","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R137-4-20250124","doi-asserted-by":"crossref","first-page":"664668","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation.","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"R138-4-20250124","doi-asserted-by":"crossref","first-page":"267272","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"key":"R139-4-20250124","doi-asserted-by":"crossref","first-page":"17471748","DOI":"10.1016\/S0041-1345(00)02826-8","article-title":"A cause of late graft dysfunction after liver transplantation in children: denovo autoimmune hepatitis.","volume":"33","author":"Spada","year":"2001","journal-title":"Transplant Proc"},{"key":"R140-4-20250124","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1002\/hep.510300103","article-title":"Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.","volume":"30","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"R141-4-20250124","doi-asserted-by":"crossref","first-page":"461465","DOI":"10.1053\/jlts.2001.23792","article-title":"Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis postliver transplantation.","volume":"7","author":"Tan","year":"2001","journal-title":"Liver Transpl"},{"key":"R142-4-20250124","doi-asserted-by":"crossref","first-page":"541547","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20year experience.","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"R143-4-20250124","doi-asserted-by":"crossref","first-page":"380384","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"R144-4-20250124","doi-asserted-by":"crossref","first-page":"639644","DOI":"10.1136\/gut.43.5.639","article-title":"Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.","volume":"43","author":"Papatheodoridis","year":"1998","journal-title":"Gut"},{"key":"R145-4-20250124","first-page":"279282","article-title":"A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.","volume":"92","author":"Riley","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R146-4-20250124","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R147-4-20250124","doi-asserted-by":"crossref","first-page":"205211","DOI":"10.1080\/00365520500206293","article-title":"Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.","volume":"41","author":"Verdonk","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"R148-4-20250124","doi-asserted-by":"crossref","first-page":"685690","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"R149-4-20250124","doi-asserted-by":"crossref","first-page":"19831988","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"R150-4-20250124","doi-asserted-by":"crossref","first-page":"225232","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"key":"R151-4-20250124","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.151.2.1039","article-title":"Cyclosporin A-induced autoimmune disease in mice.","volume":"151","author":"Bucy","year":"1993","journal-title":"J Immunol"},{"key":"R152-4-20250124","doi-asserted-by":"crossref","first-page":"625626","DOI":"10.1038\/339625a0","article-title":"Cyclosporin A inhibits activationinduced cell death in Tcell hybridomas and thymocytes.","volume":"339","author":"Shi","year":"1989","journal-title":"Nature"},{"key":"R153-4-20250124","doi-asserted-by":"crossref","first-page":"390399","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4CD25 regulatory Tcell function by calcineurindependent interleukin2 production.","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"key":"R154-4-20250124","doi-asserted-by":"crossref","first-page":"65196523","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL2 is critically required for the in vitro activation of CD4CD25 T cell suppressor function.","volume":"172","author":"Thornton","year":"2004","journal-title":"J Immunol"},{"key":"R155-4-20250124","doi-asserted-by":"crossref","first-page":"277284","DOI":"10.1002\/lt.20612","article-title":"Low circulating regulatory Tcell levels after acute rejection in liver transplantation.","volume":"12","author":"Demirkiran","year":"2006","journal-title":"Liver Transpl"},{"key":"R156-4-20250124","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4()CD25() regulatory Tcells in autoimmune liver disease.","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"R157-4-20250124","first-page":"535539","article-title":"Antibodies against glutathione Stransferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.","volume":"126","author":"Aguilera","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R158-4-20250124","first-page":"11261129","article-title":"Antibodies against glutathione Stransferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: longterm followup after liver transplantation.","volume":"83","author":"RodriguezMahou","year":"2007","journal-title":"Transplantation"},{"key":"R159-4-20250124","doi-asserted-by":"crossref","first-page":"530539","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with antiglutathione Stransferase T1 antibodies after liver transplantation.","volume":"15","author":"Salcedo","year":"2009","journal-title":"Liver Transpl"},{"issue":"suppl 4","key":"R160-4-20250124","first-page":"635A636A","article-title":"Glutathionine Stransferase theta 1 (GSTT1) mismatch does not account for post liver transplant de novo autoimmune hepatitis abstract.","volume":"50","author":"Grammatikopoulos","year":"2009","journal-title":"Hepatology"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.23704","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.23704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201310000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:30:30Z","timestamp":1737739830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201310000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":152,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.23704","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}